Dr. Anahita Keyhani has been named Director of Method Development at Algorithme Pharma. Dr. Keyhani brings nearly 20 years of experience and previously served as a senior research scientist at Charles River Laboratories.
 
“Dr. Keyhani is an experienced Bioanalytical Scientist with a proven record in regulated lab study management in both preclinical and clinical development. Her ability to maintain strong client relationships, manage complex projects, work and adapt to cutting-edge technology, and rally her peers, will be of great value to our large team of highly competent scientific experts,” said Chris Perkin, chief executive officer. “She will play a key role in our ongoing strategy to be the best in the business of method development for innovator drugs, both small and large molecules.”
 
Algorithme Pharma is a Québec-owned organization specializing in clinical research services for the international pharma industry. Its support services include bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology and project management. They operate out of Montréal, Québec, and Fargo, ND.